These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 26169704)

  • 1. Assessment of adherence to guidelines for using progesterone to prevent recurrent preterm birth.
    Crane SS; Naples R; Grand CK; Friebert S; McNinch NL; Kantak A; Rossi E; McBride J
    J Matern Fetal Neonatal Med; 2016; 29(11):1861-5. PubMed ID: 26169704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of progesterone to prevent preterm birth at a tertiary care center.
    Bailit JL; Berkowitz R; Thorp JM; Cleary K; Hartmann KE; Mercer BM
    J Reprod Med; 2007 Apr; 52(4):280-4. PubMed ID: 17506366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment options and recommendations to reduce preterm births in women with short cervix.
    Slager J; Lynne S
    J Midwifery Womens Health; 2012 Jul; 57 Suppl 1():S12-8. PubMed ID: 22776244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progesterone vaginal gel for the reduction of recurrent preterm birth: primary results from a randomized, double-blind, placebo-controlled trial.
    O'Brien JM; Adair CD; Lewis DF; Hall DR; Defranco EA; Fusey S; Soma-Pillay P; Porter K; How H; Schackis R; Eller D; Trivedi Y; Vanburen G; Khandelwal M; Trofatter K; Vidyadhari D; Vijayaraghavan J; Weeks J; Dattel B; Newton E; Chazotte C; Valenzuela G; Calda P; Bsharat M; Creasy GW
    Ultrasound Obstet Gynecol; 2007 Oct; 30(5):687-96. PubMed ID: 17899572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A survey of clinician and patient attitudes towards the use of progesterone for women at risk of preterm birth.
    Dodd JM; Ashwood P; Flenady V; Jenkins-Manning S; Cincotta R; Crowther CA
    Aust N Z J Obstet Gynaecol; 2007 Apr; 47(2):106-9. PubMed ID: 17355298
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of preterm delivery with vaginal progesterone in women with preterm labour (4P): randomised double-blind placebo-controlled trial.
    Martinez de Tejada B; Karolinski A; Ocampo MC; Laterra C; Hösli I; Fernández D; Surbek D; Huespe M; Drack G; Bunader A; Rouillier S; López de Degani G; Seidenstein E; Prentl E; Antón J; Krähenmann F; Nowacki D; Poncelas M; Nassif JC; Papera R; Tuma C; Espoile R; Tiberio O; Breccia G; Messina A; Peker B; Schinner E; Mol BW; Kanterewicz L; Wainer V; Boulvain M; Othenin-Girard V; Bertolino MV; Irion O;
    BJOG; 2015 Jan; 122(1):80-91. PubMed ID: 25209926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of spontaneous preterm birth: the role of sonographic cervical length in identifying patients who may benefit from progesterone treatment.
    Romero R
    Ultrasound Obstet Gynecol; 2007 Oct; 30(5):675-86. PubMed ID: 17899585
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment options and pregnancy outcome in women with idiopathic recurrent miscarriage: a randomized placebo-controlled study.
    Fawzy M; Shokeir T; El-Tatongy M; Warda O; El-Refaiey AA; Mosbah A
    Arch Gynecol Obstet; 2008 Jul; 278(1):33-8. PubMed ID: 18071727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. What agent should be used to prevent recurrent preterm birth: 17-P or natural progesterone?
    Hall NR
    Obstet Gynecol Clin North Am; 2011 Jun; 38(2):235-46, ix-x. PubMed ID: 21575799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness of transvaginal ultrasound cervical length screening in singletons without a prior preterm birth: an update.
    Werner EF; Hamel MS; Orzechowski K; Berghella V; Thung SF
    Am J Obstet Gynecol; 2015 Oct; 213(4):554.e1-6. PubMed ID: 26071914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progesterone and preterm birth prevention: translating clinical trials data into clinical practice.
    Society for Maternal-Fetal Medicine Publications Committee, with assistance of Vincenzo Berghella
    Am J Obstet Gynecol; 2012 May; 206(5):376-86. PubMed ID: 22542113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progesterone for preterm birth prevention: an evolving intervention.
    Tita AT; Rouse DJ
    Am J Obstet Gynecol; 2009 Mar; 200(3):219-24. PubMed ID: 19254577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effectiveness of progesterone in pregnancy complications].
    van der Hoorn MP; Lashley EELO
    Ned Tijdschr Geneeskd; 2019 Oct; 163():. PubMed ID: 31682091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of sub-endometrial blood flow parameters following dydrogesterone and micronized vaginal progesterone administration in women with idiopathic recurrent miscarriage: a pilot study.
    Ghosh S; Chattopadhyay R; Goswami S; Chaudhury K; Chakravarty B; Ganesh A
    J Obstet Gynaecol Res; 2014 Jul; 40(7):1871-6. PubMed ID: 25056464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of progesterone in maternal and fetal medicine.
    Di Renzo GC; Giardina I; Clerici G; Mattei A; Alajmi AH; Gerli S
    Gynecol Endocrinol; 2012 Nov; 28(11):925-32. PubMed ID: 23057618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progesterone for maintenance tocolytic therapy after threatened preterm labour: a randomised controlled trial.
    Borna S; Sahabi N
    Aust N Z J Obstet Gynaecol; 2008 Feb; 48(1):58-63. PubMed ID: 18275573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of preterm birth with vaginal progesterone or 17-alpha-hydroxyprogesterone caproate: a critical examination of efficacy and safety.
    O'Brien JM; Lewis DF
    Am J Obstet Gynecol; 2016 Jan; 214(1):45-56. PubMed ID: 26558340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaginal progesterone is associated with a decrease in risk for early preterm birth and improved neonatal outcome in women with a short cervix: a secondary analysis from a randomized, double-blind, placebo-controlled trial.
    DeFranco EA; O'Brien JM; Adair CD; Lewis DF; Hall DR; Fusey S; Soma-Pillay P; Porter K; How H; Schakis R; Eller D; Trivedi Y; Vanburen G; Khandelwal M; Trofatter K; Vidyadhari D; Vijayaraghavan J; Weeks J; Dattel B; Newton E; Chazotte C; Valenzuela G; Calda P; Bsharat M; Creasy GW
    Ultrasound Obstet Gynecol; 2007 Oct; 30(5):697-705. PubMed ID: 17899571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological use of progesterone and 17-alpha-hydroxyprogesterone caproate in the prevention of preterm delivery.
    Facchinetti F; Vaccaro V
    Minerva Ginecol; 2009 Oct; 61(5):401-9. PubMed ID: 19749671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful pregnancy in a patient suffering from recurrent mid-trimester miscarriage with C9 deficiency after receiving cervical cerclage followed by clindamycin and progesterone: a case report.
    Watanabe N; Suzuki T; Kitano E; Kitamura H; Hatanaka M; Sago H
    J Obstet Gynaecol Res; 2012 Mar; 38(3):562-6. PubMed ID: 22381107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.